Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle

Molecular Human Reproduction

Volumn 10, Issue 9, 2004, Pages 655-663

  Nordengren, J ^a   Pilka, R ^a,b   Noskova, V ^a   Ehinger, A ^a   Domanski, H ^a   Andersson, C ^a   Hoyer Hansen G ^c   Hansson, S R ^a   Casslén, Bertil ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c FINSEN LABORATORY   (Denmark)

Author keywords

Endometrium; Epithelial cells; Menstrual cycle; uPA; uPAR

Indexed keywords

MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR; SEX HORMONE; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; DECIDUA; ENDOMETRIUM; EPITHELIUM CELL; FEMALE; FOLLICULAR PHASE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUATION; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL; TISSUE DIFFERENTIATION; UTERUS FLUID;

ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MENSTRUAL CYCLE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, CELL SURFACE; URINARY PLASMINOGEN ACTIVATOR;

EID: 5044242516     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/gah081     Document Type: Article

References (37)

1. Andreasen PA, Kjøller L, Christensen L and Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72,1-22.
2. Andressen PA, Egelund R and Petersen HH (2000) The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57,25-40.
3. Bradley DJ, Towle HC and Young WS (1992) Spatial and temporal expression of a- and beta-thyroid receptor hormone receptor mRNAs, including the beta-2-subtype, in the developing mammalian nervous system. J Neurosci 12,2288-2302.
4. Casslén B and Åstedt B (1981) Fibrinolytic activity of human uterine fluid. Acta Obstet Gynecol Scand 60,55-58.
5. Casslén B and Åstedt B (1983) Occurrence of both urokinase and tissue plasminogen activator in the human endometrium. Contraception 28,553-564.
6. Casslén B and Gustavsson B (1991) Expression of cell membrane receptors for urokinase plasminogen activator (uPA) in the human endometrium increases during the ovarian cycle. Fibrinolysis 5,243-248.
7. Casslén B and Ohlsson K (1981) Cyclic variation of plasminogen activation in human uterine fluid, and the influence of an intrauterine device. Acta Obstet Gynecol Scand 60,97-101.
8. Casslén B, Thorell J and Åstedt B (1981) Effect of IUD on urokinase-like immunoreactivity and plasminogen activators in human uterine fluid. Contraception 23,435-446.
9. Casslén B, Andersson A, Nilsson I and Åstedt B (1986) Hormonal regulation of the release of plasminogen activators and of a specific activator inhibitor from endometrial tissue in culture. Proc Soc Exp Biol Med 182, 419-424.
10. Casslén B, Siler-Khodr T and Harper M (1990) Progesterone regulation of prolactin release from human endometrial stromal cells in culture: Potential bioassay for progestational activity. Acta Endocrinol 122,137-144.
11. Casslén B, Urano S, Lecander I and Ny T (1992a) Plasminogen activators in the human endometrium, cellular origin and hormonal regulation. Blood Coag Fibrinolys 3,133-138.
12. Casslén B, Urano S and Ny T (1992b) Progesterone regulation of plasminogen activator inhibitor 1 (PAI-1) antigen and mRNA levels in human endometrial stromal cells. Thromb Res 66,75-87.
13. Casslén B, Nordengren J, Gustavsson B, Nilbert M and Lund LR (1995) Progesterone stimulates degradation of urokinase plasminogen activator (u-PA) in endometrial stromal cells by increasing its inhibitor (PAI-1) and surface expression of the u-PA receptor. J Clin Endocrinol Metab 80, 2776-2784.
14. Casslén B, Gustavsson B, Angelin B and Gåfvels M (1998) Degradation of urokinase plasminogen activator (UPA) in endometrial stromal cells requires both the UPA receptor and the low-density lipoprotein receptor-related protein/α2-macroglobulin receptor. Mol Hum Reprod 4, 585-593.
15. Chavakis T, Kanse SM, Yutzy B, Lijnen HR and Preissner KT (1998) Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes. Blood 91,2305-2312.
16. Cubellis MV, Wun TC and Blasi F (1990) Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J 9,1079-10785.
17. Gleeson NC (1994) Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia. Am J Obstet Gynecol 171, 178-183.
18. Hendrickson MR and Kempson RL (1980) Surgical Pathology of the Uterine Corpus. Saunders, Philadelphia.
19. Koh SCL, Wong PC, Yuen R, Chua SE, Ng BL and Ratnam SS (1992) Concentration of plasminogen activators and inhibitor in the human endometrium at different phases of the menstrual cycle. J Reprod Fertil 96, 407-413.
20. Liedholm P and Åstedt B (1976) Inhibitory effect of decidua on fibrinolysis induced by urokinase and by the fibrinolytic activity of the rat ovum. Acta Obstet Gynecol Scand 55,217-219.
21. Mizukami IF and Todd RF (1998) A soluble form of the urokinase plasminogen activator receptor (suPAR) can bind to hematopoietic cells. J Leukoc Biol 64,203-213.
22. Nordengren J, Casslén B and Lecander I (1996) Plasminogen activator inhibitor 2 in menstrual endometrium and in primary cultures of endometrial cells. Fibrinolysis 10,295-302.
23. Nordengren J, Casslén B, Gustavsson B, Einarsdottir M and Willén R (1998) Discordant expression of mRNA and protein for urokinase and tissue plasminogen activators (u-PA, t-PA) in endometrial carcinoma. Int J Cancer 79,195-201.
24. Noyes RW, Hertig AT and Rock J (1950) Dating the endometrial biopsy. Fertil Steril 1,3-25.
25. Ny T, Sawdey M, Lawrence D, Millan J and Loskutoff D (1986) Cloning and sequence of a cDNA coding for the human β-migrating endothelial-cell-type plasminogen activator inhibitor. Proc Natl Acad Sci USA 83, 6776-6780.
26. Nykjaer A, Petersen CM, Möller B, Jensen PH, Moestrup SK, Holtet TL, Etzerodt M, Thögersen HC, Munch M, Andreasen PA and Gliemann J (1992) Purified α2-macroglobulin receptor/LDL receptor-related protein binds urokinase plasminogen activator inhibitor type-1 complex. J Biol Chem 267,14543-14546.
27. Riisbro R, Piironen T, Brunner N, Larsen B, Nielsen HJ, Stephens RW and Hoyer-Hansen G (2002) Measurement of soluble urokinase plasminogen activator receptor in serum. J Clin Ligand Assay 25,53-56.
28. Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Danø K, Appella E and Blasi F (1990) Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J 9,467-474.
29. Rybo G (1966) Plasminogen activators in the endometrium. Acta Obstet Gynecol Scand 45,97-118.
30. Rønne E, Pappot H, Grøndahl-Hansen J, Høyer-Hansen G, Plesner T, Hansen NE and Danø K (1995) The receptors for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal hemoglobinuria. Br J Haematol 89,576-581.
31. Sandberg T, Eriksson P, Gustavsson B and Casslén B (1997) Differential regulation of the plasminogen activator inhibitor-1 (PAI-1) gene expression by growth factors and progesterone in endometrial stromal cells. Mol Hum Reprod 3,781-787.
32. Sandberg T, Casslén B, Gustavsson B and Benraad TJ (1998) Human endothelial cell migration is stimulated by urokinase plasminogen activator: plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor β1; possible mechanism for paracrine stimulation of endometrial angiogenesis. Biol Reprod 59,759-767.
33. Schatz F and Lockwood CJ (1993) Progestin regulation of plasminogen activator inhibitor type-1 in primary cultures of endometrial stromal and decidual cells. J Clin Endocrinol Metab 77,621-625.
34. Shi SR, Key ME and Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39,741-748.
35. Verde P, Stoppelli MP, Galeffi P, Dinocera PP and Blasi F (1984) Identification and primary sequence of an unspliced human urokinase poly(A) + RNA. Proc Natl Acad Sci USA 81,4727-4731.
36. Wahlberg K, Høyer-Hansen G and Casslén B (1998) Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer. Cancer Res 58,3294-3298.
37. Young WS (1990) In situ hybridization histochemistry. In Björklund A, Hökfelt T, Wouterlood FG and van den Pol AN (eds), Handbook of Chemical Neuroanatomy: Analysis of Neuronal Microcircuits and Synaptic Interactions. Elsevier, Vol 8, pp 481-512.